Basics Galecto, Inc. Common Stock IPO Date: October 29, 2020 Sector: Healthcare Industry: Biotech Market Cap: $3.99M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 3.87% Avg Daily Range (30 D): $0.07 | 2.11% Avg Daily Range (90 D): $0.10 | 3.04% Institutional Daily Volume Avg Daily Volume: .18M Avg Daily Volume (30 D): .01M Avg Daily Volume (90 D): .03M Trade Size Avg Trade Size (Sh.): 199 Avg Trade Size (Sh.) (30 D): 144 Avg Trade Size (Sh.) (90 D): 90 Institutional Trades Total Inst.Trades: 15 Avg Inst. Trade: $2.23M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.61M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 8.07K     News Feb 6, 2025 @ 1:00 PM Galecto to Participate in Upcoming Investor Confer... Source: N/A Oct 7, 2024 @ 12:45 PM Galecto Completes Strategic Review to Focus on Onc... Source: N/A May 1, 2024 @ 8:01 PM Galecto Announces First Patient Dosed in an Invest... Source: Galecto, Inc. Feb 14, 2024 @ 5:00 PM Galecto, Inc. (GLTO) Upgraded to Strong Buy: What ... Source: Zacks Equity Research Feb 14, 2024 @ 10:48 AM New Strong Buy Stocks for February 14th Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-13.08 $-2.6 $-1.92 Diluted EPS $-13.08 $-2.6 $-1.92 Revenue $ .5M $ .05M $ .07M Gross Profit $ $ $ Net Income / Loss $ -16.56M $ -3.4M $ -2.53M Operating Income / Loss $ -16.96M $ -3.42M $ -2.6M Cost of Revenue $ $ $ Net Cash Flow $ -3.86M $ -1.73M $ -2.24M PE Ratio     Splits Aug 30, 2024:   1:25